Literature DB >> 33547340

Extracellular DNA, cell surface proteins and c-di-GMP promote biofilm formation in Clostridioides difficile.

Lisa F Dawson1, Johann Peltier2,3, Catherine L Hall2, Mark A Harrison2, Maria Derakhshan2, Helen A Shaw2,4, Neil F Fairweather5, Brendan W Wren2.   

Abstract

Clostridioides difficile is the leading cause of nosocomial antibiotic-associated diarrhoea worldwide, yet there is little insight into intestinal tract colonisation and relapse. In many bacterial species, the secondary messenger cyclic-di-GMP mediates switching between planktonic phase, sessile growth and biofilm formation. We demonstrate that c-di-GMP promotes early biofilm formation in C. difficile and that four cell surface proteins contribute to biofilm formation, including two c-di-GMP regulated; CD2831 and CD3246, and two c-di-GMP-independent; CD3392 and CD0183. We demonstrate that C. difficile biofilms are composed of extracellular DNA (eDNA), cell surface and intracellular proteins, which form a protective matrix around C. difficile vegetative cells and spores, as shown by a protective effect against the antibiotic vancomycin. We demonstrate a positive correlation between biofilm biomass, sporulation frequency and eDNA abundance in all five C. difficile lineages. Strains 630 (RT012), CD305 (RT023) and M120 (RT078) contain significantly more eDNA in their biofilm matrix than strains R20291 (RT027) and M68 (RT017). DNase has a profound effect on biofilm integrity, resulting in complete disassembly of the biofilm matrix, inhibition of biofilm formation and reduced spore germination. The addition of exogenous DNase could be exploited in treatment of C. difficile infection and relapse, to improve antibiotic efficacy.

Entities:  

Year:  2021        PMID: 33547340      PMCID: PMC7865049          DOI: 10.1038/s41598-020-78437-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  100 in total

1.  Novel strategy for biofilm inhibition by using small molecules targeting molecular chaperone DnaK.

Authors:  Ken-ichi Arita-Morioka; Kunitoshi Yamanaka; Yoshimitsu Mizunoe; Teru Ogura; Shinya Sugimoto
Journal:  Antimicrob Agents Chemother       Date:  2014-11-17       Impact factor: 5.191

Review 2.  Microbial biofilms.

Authors:  J W Costerton; Z Lewandowski; D E Caldwell; D R Korber; H M Lappin-Scott
Journal:  Annu Rev Microbiol       Date:  1995       Impact factor: 15.500

Review 3.  Extracellular DNA in biofilms.

Authors:  Lucio Montanaro; Alessandro Poggi; Livia Visai; Stefano Ravaioli; Davide Campoccia; Pietro Speziale; Carla Renata Arciola
Journal:  Int J Artif Organs       Date:  2011-09       Impact factor: 1.595

4.  Cyclic di-GMP riboswitch-regulated type IV pili contribute to aggregation of Clostridium difficile.

Authors:  Eric Bordeleau; Erin B Purcell; Daniel A Lafontaine; Louis-Charles Fortier; Rita Tamayo; Vincent Burrus
Journal:  J Bacteriol       Date:  2014-12-15       Impact factor: 3.490

Review 5.  Virulence factors of Clostridium difficile and their role during infection.

Authors:  Claire Janoir
Journal:  Anaerobe       Date:  2015-10-24       Impact factor: 3.331

6.  The role of bacterial biofilms in chronic infections.

Authors:  Thomas Bjarnsholt
Journal:  APMIS Suppl       Date:  2013-05

7.  Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium.

Authors:  Richard A Stabler; Miao He; Lisa Dawson; Melissa Martin; Esmeralda Valiente; Craig Corton; Trevor D Lawley; Mohammed Sebaihia; Michael A Quail; Graham Rose; Dale N Gerding; Maryse Gibert; Michel R Popoff; Julian Parkhill; Gordon Dougan; Brendan W Wren
Journal:  Genome Biol       Date:  2009-09-25       Impact factor: 13.583

8.  Clostridium difficile secreted Pro-Pro endopeptidase PPEP-1 (ZMP1/CD2830) modulates adhesion through cleavage of the collagen binding protein CD2831.

Authors:  Paul J Hensbergen; Oleg I Klychnikov; Dennis Bakker; Irina Dragan; Michelle L Kelly; Nigel P Minton; Jeroen Corver; Ed J Kuijper; Jan Wouter Drijfhout; Hans C van Leeuwen
Journal:  FEBS Lett       Date:  2015-10-29       Impact factor: 4.124

9.  Broad impact of extracellular DNA on biofilm formation by clinically isolated Methicillin-resistant and -sensitive strains of Staphylococcus aureus.

Authors:  Shinya Sugimoto; Fumiya Sato; Reina Miyakawa; Akio Chiba; Shoichi Onodera; Seiji Hori; Yoshimitsu Mizunoe
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

Review 10.  Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection.

Authors:  Duolong Zhu; Joseph A Sorg; Xingmin Sun
Journal:  Front Cell Infect Microbiol       Date:  2018-02-08       Impact factor: 5.293

View more
  6 in total

Review 1.  The biofilm matrix: multitasking in a shared space.

Authors:  Hans-Curt Flemming; Eric D van Hullebusch; Thomas R Neu; Per H Nielsen; Thomas Seviour; Paul Stoodley; Jost Wingender; Stefan Wuertz
Journal:  Nat Rev Microbiol       Date:  2022-09-20       Impact factor: 78.297

2.  Inhibition of In Vitro Clostridioides difficile Biofilm Formation by the Probiotic Yeast Saccharomyces boulardii CNCM I-745 through Modification of the Extracellular Matrix Composition.

Authors:  Pierre-Alexandre Lacotte; Alexis Simons; Sylvie Bouttier; Jeanne Malet-Villemagne; Valérie Nicolas; Claire Janoir
Journal:  Microorganisms       Date:  2022-05-24

3.  Production of p-cresol by Decarboxylation of p-HPA by All Five Lineages of Clostridioides difficile Provides a Growth Advantage.

Authors:  Mark A Harrison; Harparkash Kaur; Brendan W Wren; Lisa F Dawson
Journal:  Front Cell Infect Microbiol       Date:  2021-10-29       Impact factor: 5.293

Review 4.  Microbial resistance to nanotechnologies: An important but understudied consideration using antimicrobial nanotechnologies in orthopaedic implants.

Authors:  Zhuoran Wu; Brian Chan; Jessalyn Low; Justin Jang Hann Chu; Hwee Weng Dennis Hey; Andy Tay
Journal:  Bioact Mater       Date:  2022-03-03

Review 5.  Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Livio Enrico Del Vecchio; Marcello Fiorani; Ege Tohumcu; Stefano Bibbò; Serena Porcari; Maria Cristina Mele; Marco Pizzoferrato; Antonio Gasbarrini; Giovanni Cammarota; Gianluca Ianiro
Journal:  Microorganisms       Date:  2022-06-29

6.  Recognition of extracellular DNA by type IV pili promotes biofilm formation by Clostridioides difficile.

Authors:  Leslie A Ronish; Ben Sidner; Yafan Yu; Kurt H Piepenbrink
Journal:  J Biol Chem       Date:  2022-09-03       Impact factor: 5.486

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.